DK0539525T3 - Vitalethein og anvendelse deraf i cellekultur og terapi - Google Patents
Vitalethein og anvendelse deraf i cellekultur og terapiInfo
- Publication number
- DK0539525T3 DK0539525T3 DK91915854T DK91915854T DK0539525T3 DK 0539525 T3 DK0539525 T3 DK 0539525T3 DK 91915854 T DK91915854 T DK 91915854T DK 91915854 T DK91915854 T DK 91915854T DK 0539525 T3 DK0539525 T3 DK 0539525T3
- Authority
- DK
- Denmark
- Prior art keywords
- vitalethein
- therapy
- cell culture
- vitaletheine
- cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0025—Culture media for plant cell or plant tissue culture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54944090A | 1990-07-06 | 1990-07-06 | |
| US54910590A | 1990-07-06 | 1990-07-06 | |
| US54943890A | 1990-07-06 | 1990-07-06 | |
| PCT/US1991/004726 WO1992000955A1 (en) | 1990-07-06 | 1991-07-08 | Vitaletheine and use in cell culture and therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0539525T3 true DK0539525T3 (da) | 2000-04-10 |
Family
ID=27415550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91915854T DK0539525T3 (da) | 1990-07-06 | 1991-07-08 | Vitalethein og anvendelse deraf i cellekultur og terapi |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0539525B1 (https=) |
| JP (1) | JP3259960B2 (https=) |
| AT (1) | ATE186048T1 (https=) |
| AU (1) | AU655598B2 (https=) |
| DE (1) | DE69131752T2 (https=) |
| DK (1) | DK0539525T3 (https=) |
| ES (1) | ES2139580T3 (https=) |
| GR (1) | GR3031801T3 (https=) |
| WO (1) | WO1992000955A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6007819A (en) * | 1995-10-17 | 1999-12-28 | Dovetail Technologies, Inc. | Methods of inducing immunity using low molecular weight immune stimulants |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4552765A (en) * | 1982-05-14 | 1985-11-12 | Santen Pharmaceutical Co., Ltd. | Aletheine derivatives |
| ES2080954T3 (es) * | 1990-07-06 | 1996-02-16 | Univ New Mexico | Uso de beta-aletina en cultivos de celulas y en terapia. |
-
1991
- 1991-07-08 DE DE69131752T patent/DE69131752T2/de not_active Expired - Fee Related
- 1991-07-08 ES ES91915854T patent/ES2139580T3/es not_active Expired - Lifetime
- 1991-07-08 WO PCT/US1991/004726 patent/WO1992000955A1/en not_active Ceased
- 1991-07-08 AT AT91915854T patent/ATE186048T1/de not_active IP Right Cessation
- 1991-07-08 DK DK91915854T patent/DK0539525T3/da active
- 1991-07-08 EP EP91915854A patent/EP0539525B1/en not_active Expired - Lifetime
- 1991-07-08 AU AU85008/91A patent/AU655598B2/en not_active Ceased
- 1991-07-08 JP JP51462891A patent/JP3259960B2/ja not_active Expired - Fee Related
-
1999
- 1999-11-10 GR GR990402894T patent/GR3031801T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1992000955A1 (en) | 1992-01-23 |
| ATE186048T1 (de) | 1999-11-15 |
| JP3259960B2 (ja) | 2002-02-25 |
| GR3031801T3 (en) | 2000-02-29 |
| AU655598B2 (en) | 1995-01-05 |
| DE69131752D1 (de) | 1999-12-02 |
| EP0539525B1 (en) | 1999-10-27 |
| EP0539525A4 (https=) | 1994-01-12 |
| JPH06500106A (ja) | 1994-01-06 |
| AU8500891A (en) | 1992-02-04 |
| DE69131752T2 (de) | 2000-06-29 |
| HK1014367A1 (en) | 1999-09-24 |
| EP0539525A1 (en) | 1993-05-05 |
| ES2139580T3 (es) | 2000-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE347585T1 (de) | In-vitro wachstum von langerhans'schen inseln und ihre verwendungen | |
| DE60009956D1 (de) | Wachstumsfaktoren und l-glutamin enthaltendes zellkulturmedium | |
| BR9910251A (pt) | Estimulação hematopoiética | |
| BR0210599A (pt) | Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril | |
| TR201903587T4 (tr) | Telomeraz aktivitesinin artırılması için bileşimler. | |
| ES2074867T3 (es) | Derivados de quinazolina para potenciar la actividad antitumoral. | |
| AR241314A1 (es) | Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional. | |
| ES2151607T3 (es) | Factor 12 de crecimiento y de diferenciacion. | |
| UA29466C2 (uk) | Фармацевтична композиція з антипухлинною активністю | |
| EE9700225A (et) | Meetod diabetes mellituse raviks, kasutades KKF | |
| DE69535081D1 (de) | Verwendung von Prostaglandin A oder dessen Derivaten zur Behandlung von Psoriasis | |
| FI920430A0 (fi) | Benzyloxifenylderivator. | |
| PT809437E (pt) | Tiois para promover crescimento de celulas progenitoras hematopoieticas | |
| PT862452E (pt) | Formulacao de estabilizacao para o ngf | |
| EP0380692A4 (en) | Plant tissue culture process | |
| DE3850778D1 (de) | Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks. | |
| ES2068714T3 (es) | Derivados de pirimidina para aumentar la actividad antitumoral. | |
| DK0539525T3 (da) | Vitalethein og anvendelse deraf i cellekultur og terapi | |
| DK0538330T3 (da) | Beta-Alethin-anvendelse til celledyrkning og terapi | |
| ATE124262T1 (de) | Verwendung von wirtszellphospholipiden zur hemmung bakterieller besiedlung. | |
| ATE23112T1 (de) | Verwendung von 1-(p-isopropoxyethoxymethylphenoxy)-3-isopropylamino-propan-2-ol zur herstellung eines arzneimittels zur senkung des augeninnendrucks. | |
| PT883406E (pt) | Utilizacao da il-7 no tratamento das doencas auto-imunes em particular a diabetes mellitus insulinodependente | |
| FR2835429B1 (fr) | Utilisation d'acide ascorbique pour renforcer la cohesion de la jonction dermo-epidermique | |
| ES2057528T3 (es) | Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen. | |
| ES8801624A1 (es) | Procedimiento para preparar disulfuros heterociclicos |